Contemporary data confirm that there has been racial diversification in clinical trials over the past 20 years, yet minority participation in trials still lags behind their share of the U.S. population. Experts agree that provider education and care navigators are key to enrolling traditionally underrepresented groups in trials, but widespread implementation of these strategies is needed.

You do not currently have access to this content.